CN1111522A - Compound islets Langerhans regenerated capsule - Google Patents
Compound islets Langerhans regenerated capsule Download PDFInfo
- Publication number
- CN1111522A CN1111522A CN 95101100 CN95101100A CN1111522A CN 1111522 A CN1111522 A CN 1111522A CN 95101100 CN95101100 CN 95101100 CN 95101100 A CN95101100 A CN 95101100A CN 1111522 A CN1111522 A CN 1111522A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- regenerated
- compound
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of capsule for reviving islets Langerhans and the preparation thereof. It is made from pure traditional Chinese medicinal ingredients. It features convenient for making, simple technology, through the clinical application, it not only has the obviously curative effect for diabetes but also has the outstanding result for diabetes mode I. There is no toxic side effect. The part of diabetic patients can be cured by this medicine.
Description
The present invention relates to a kind of compound islets Langerhans regenerated capsule for the treatment of type and preparation method thereof.
It is also many to suffer from the type person at present, their health mostly is under the internal and external factor influence, the islet cells that causes the pancreatic endocrine insulin, be seriously damaged, basically completely lost the function of normal excreting insulin, be a kind of extremely serious difficult pertinacious disease, particularly the life and health to youngsters and children is subjected to fatal threat.The unique better means of these type diabetes of treatment rely on insulin injection to earn a bare living exactly throughout one's life every day at present, and this results in hand cramps not only for patient and family members, and causes the lethal danger of hypoglycemic coma sometimes, finally can't solve root problem.
The objective of the invention is to avoid above-mentioned existing medicine weak point and for a kind of scientific formulation, simple for production, have no side effect, particularly type is had compound islets Langerhans regenerated capsule of outstanding curative effect and preparation method thereof.
Purpose of the present invention can realize by following measure: the present invention and preparation method thereof is by following component (by anharmonic ratio): Rhizoma Coptidis 2-10%, Radix Astragali 3-9%, Fructus Lycii 3-9%, Herba Patriniae 2-10%, Radix Salviae Miltiorrhizae 1-12%, Radix Angelicae Sinensis 1-10%, Radix Puerariae 3-10%, Radix Codonopsis 3-8%, Rhizoma Anemarrhenae 2-8%, Radix Scrophulariae 2-8%, Rhizoma Chuanxiong 1-9%, Radix Paeoniae Rubra 2-8%, Rhizoma Dioscoreae 1-9%, Rhizoma Polygonati 1-10%, Cortex Lycii 2-10%, Radix Rehmanniae 2-9%, Radix Rehmanniae Preparata 2-9%, Rhizoma Atractylodis 1-10%, Radix Ophiopogonis 2-9%, Poria 1-10%, Fructus Schisandrae Chinensis 1-5% etc. are formulated.
Optimum proportion of the present invention is (weight ratio): Rhizoma Coptidis 4-8%, Radix Astragali 4-8%, Fructus Lycii 4-8%, Herba Patriniae 4-8%, Radix Salviae Miltiorrhizae 4-8%, Radix Angelicae Sinensis 4-8%, Radix Puerariae 4-8%, Radix Codonopsis 3-7%, Rhizoma Anemarrhenae 3-7%, Radix Scrophulariae 3-7%, Rhizoma Chuanxiong 2-6%, Radix Paeoniae Rubra 2-6%, Rhizoma Dioscoreae 2-6%, Rhizoma Polygonati 2-6%, Cortex Lycii 2-6%, Radix Rehmanniae 2-6%, Radix Rehmanniae Preparata 2-6%, Rhizoma Atractylodis 2-6%, Radix Ophiopogonis 2-6%, Poria 2-6%, Fructus Schisandrae Chinensis 1-4%.
Preparation method of the present invention is: the component (weight ratio) of getting the Chinese medicine of respectively distinguishing the flavor of in the above-mentioned batching cleans up, put into 100 ℃ then and open the water that boils, sterilized 20-60% minute, pull each flavor Chinese medicine out oven dry again, be ground into smalls and mix homogeneously, promptly make medicine of the present invention in incapsulating.
To the above-mentioned best sterilization time of the Chinese medicine of respectively distinguishing the flavor of is 45 minutes.
The invention has the advantages that: production technology is simple, easy to make, has significant curative effect through clinical use treatment type, overcome the disadvantage of insulin injection, without any side effects again, the effect that can recover the normal excreting insulin of islet cells fully through taking for a long time is to reach the purpose of radical cure diabetes.
Further the present invention is illustrated with the following examples, but does not limit the present invention.
The embodiment I:
Get the percentage by weight of the Chinese medicine of respectively distinguishing the flavor of of the present invention, it is respectively: Rhizoma Coptidis 6%, the Radix Astragali 6%, Fructus Lycii 6%, Herba Patriniae 6%, Radix Salviae Miltiorrhizae 6%, Radix Angelicae Sinensis 6%, Radix Puerariae 6%, Radix Codonopsis 5%, the Rhizoma Anemarrhenae 5%, Radix Scrophulariae 5%, Rhizoma Chuanxiong 4%, Radix Paeoniae Rubra 4%, Rhizoma Dioscoreae 4%, Rhizoma Polygonati 4%, Cortex Lycii 4%, the Radix Rehmanniae 4%, Radix Rehmanniae Preparata 4%, Rhizoma Atractylodis 4%, Radix Ophiopogonis 4%, Poria 4%, Fructus Schisandrae Chinensis 3%, above-mentioned various Chinese medicines are cleaned up, put into 100 ℃ then and open the water that boils, sterilized 30 minutes, pull oven dry out, be ground into smalls, mix homogeneously is promptly made Chinese patent drug of the present invention in incapsulating.
Case 1: Zhu * *, the woman, 11 years old, the Zhengzhou Railway Administration families of workers and staff, suffered from type 3 years, every day, insulin injection was 3-4 time, per injection 24 μ, but blood glucose is still more than 11.2mm01/L, glucose in urine (++)-(++ ++) is through obeying compound islets Langerhans regenerated capsule of the present invention after two courses of treatment, stop the injection of insulin treatment fully, blood glucose maintains 4.5~6.0mm01/L always, glucose in urine (-) ketoboidies (-).
Embodiment 2:
Get the percentage by weight of the Chinese medicine of respectively distinguishing the flavor of of the present invention, be respectively: Rhizoma Coptidis 5%, the Radix Astragali 5%, Fructus Lycii 5%, Herba Patriniae 5%, Radix Salviae Miltiorrhizae 5%, Radix Angelicae Sinensis 5%, Radix Puerariae 5%, Radix Codonopsis 6%, the Rhizoma Anemarrhenae 6%, Radix Scrophulariae 6%, Rhizoma Chuanxiong 6%, Radix Paeoniae Rubra 6%, Rhizoma Dioscoreae 6%, Rhizoma Polygonati 6%, Cortex Lycii 3%, the Radix Rehmanniae 3%, Radix Rehmanniae Preparata 3%, Rhizoma Atractylodis 6%, Radix Ophiopogonis 3%, Poria 3%, Fructus Schisandrae Chinensis 2%, the above-mentioned Chinese medicine of respectively distinguishing the flavor of is cleaned up, put into 100 ℃ then and open the water that boils, sterilized 35 minutes, pull oven dry out, be ground into smalls, mix homogeneously is promptly made Chinese patent drug of the present invention in incapsulating.
Case 2: the merchant * *, the man, 15 years old, the Jiaozuo City people suffered from type insulin injection always over 3 years, each 16 μ, three times on the one, blood glucose is more than 15.6mm01/L, and glucose in urine (+++) is to (++ ++), and ketoacidosis once took place for several times in ketoboidies (+).Obey medicine of the present invention after four courses of treatment, stop insulinize, about blood glucose 5.2mm01/L, ketoacidosis did not take place in glucose in urine (-).
Example 3:
Get the Chinese medicine percentage by weight of respectively distinguishing the flavor of of the present invention, be respectively: Rhizoma Coptidis 4%, the Radix Astragali 4%, Fructus Lycii 4%, Herba Patriniae 4%, Radix Salviae Miltiorrhizae 4%, Radix Angelicae Sinensis 4%, Radix Puerariae 4%, Radix Codonopsis 4%, the Rhizoma Anemarrhenae 4%, Radix Scrophulariae 4%, Rhizoma Chuanxiong 3%, Radix Paeoniae Rubra 5%, Rhizoma Dioscoreae 5%, Rhizoma Polygonati 7%, Cortex Lycii 7%, the Radix Rehmanniae 6%, Radix Rehmanniae Preparata 6%, Rhizoma Atractylodis 5%, Radix Ophiopogonis 6%, Poria 6%, Fructus Schisandrae Chinensis 4%, the above-mentioned Chinese medicine of respectively distinguishing the flavor of is cleaned up, put into 100 ℃ then and open the water that boils, sterilized 40 minutes, pull oven dry out, be ground into smalls, mix homogeneously is promptly made Chinese patent drug of the present invention in incapsulating.
Case 3: horse * *, the woman, 62 years old, certain provincial hospital internal medicine was paid the chief physician, suffered from type 32 years, per injection insulin 28 μ, three times on the one, blood glucose is more than 7.3mm01/L, and glucose in urine (+) the hypoglycemia symptom occurred to (++ ++).After six courses of treatment, stop the injection of insulin treatment, and blood glucose maintains 4.1-6.0mm01/L through clothes medicine of the present invention, the hypoglycemia symptom did not take place in glucose in urine (-), ketoboidies (-).
Claims (4)
1, a kind of compound islets Langerhans regenerated capsule for the treatment of type, it is characterized in that: it is by following component (by weight): Rhizoma Coptidis 2-10%, Radix Astragali 3-9%, Fructus Lycii 3-9%, Herba Patriniae 2-10%, Radix Salviae Miltiorrhizae 1-12%, Radix Angelicae Sinensis 1-10%, Radix Puerariae 3-10%, Radix Codonopsis 3-8%, Rhizoma Anemarrhenae 2-8%, Radix Scrophulariae 2-8%, Rhizoma Chuanxiong 1-9%, Radix Paeoniae Rubra 2-8%, Rhizoma Dioscoreae 1-9%, Rhizoma Polygonati 1-10%, Cortex Lycii 2-10%, Radix Rehmanniae 2-9%, Radix Rehmanniae Preparata 2-9%, Rhizoma Atractylodis 1-10%, Radix Ophiopogonis, 2-9%, Poria 1-10%, Fructus Schisandrae Chinensis 1-5% etc. were formulated.
2, compound islets Langerhans regenerated capsule according to claim 1, it is characterized in that its optimum proportion (weight ratio) is: Rhizoma Coptidis 4-8%, Radix Astragali 4-8%, Fructus Lycii 4-8%, Herba Patriniae 4-8%, Radix Salviae Miltiorrhizae 4-8%, Radix Angelicae Sinensis 4-8%, Radix Puerariae 4-8%, Radix Codonopsis 3-7%, Rhizoma Anemarrhenae 3-7%, Radix Scrophulariae 3-7%, Rhizoma Chuanxiong 2-6%, Radix Paeoniae Rubra 2-6%, Rhizoma Dioscoreae 2-6%, Rhizoma Polygonati 2-6%, Cortex Lycii 2-6%, Radix Rehmanniae 2-6%, Radix Rehmanniae Preparata 2-6, Rhizoma Atractylodis 2-6%, Radix Ophiopogonis 2-6%, Poria 2-6%, Fructus Schisandrae Chinensis 1-4%.
3, a kind of preparation method for the treatment of the compound islets Langerhans regenerated capsule of type, it is characterized in that: with Rhizoma Coptidis, the Radix Astragali, Fructus Lycii, Herba Patriniae, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Puerariae, Radix Codonopsis, the Rhizoma Anemarrhenae, Radix Scrophulariae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Rhizoma Dioscoreae, Rhizoma Polygonati, Cortex Lycii, the Radix Rehmanniae, Radix Rehmanniae Preparata, Rhizoma Atractylodis, Radix Ophiopogonis, Poria, Fructus Schisandrae Chinensis etc., getting the above-mentioned Chinese medicine component (weight ratio) of respectively distinguishing the flavor of cleans up, put into 100 ℃ then and open the water that boils, sterilized 20~60 minutes, pull each flavor Chinese medicine out oven dry again, be ground into smalls and mix homogeneously, promptly make medicine of the present invention in incapsulating.
4, the preparation method of compound islets Langerhans regenerated capsule according to claim 3 is characterized in that: the best sterilization time of each Chinese medicine of distinguishing the flavor of is 45 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 95101100 CN1111522A (en) | 1995-01-10 | 1995-01-10 | Compound islets Langerhans regenerated capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 95101100 CN1111522A (en) | 1995-01-10 | 1995-01-10 | Compound islets Langerhans regenerated capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1111522A true CN1111522A (en) | 1995-11-15 |
Family
ID=5073801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 95101100 Pending CN1111522A (en) | 1995-01-10 | 1995-01-10 | Compound islets Langerhans regenerated capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1111522A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1067260C (en) * | 1997-05-08 | 2001-06-20 | 曾力群 | Pure Chinese drug tangniaojing for curing diabetes |
CN1071120C (en) * | 1996-03-06 | 2001-09-19 | 宫君平 | Shihua drink made from traditional Chinese medicine |
CN1075735C (en) * | 1999-09-07 | 2001-12-05 | 阎纯义 | Compound diabetes-treating Chinese medicine preparation |
CN100415270C (en) * | 2000-10-20 | 2008-09-03 | 孙喆 | Diabetes treating medicine |
CN102614405A (en) * | 2012-04-06 | 2012-08-01 | 刘英晓 | Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy |
CN103463407A (en) * | 2013-03-24 | 2013-12-25 | 季成玉 | Body regulating and blood sugar reducing capsule |
CN103690768A (en) * | 2013-11-18 | 2014-04-02 | 山西五台山沙棘制品有限公司 | Creeping liriope-figwort-milkvetch root soft capsules and preparation method thereof |
CN104352863A (en) * | 2014-11-14 | 2015-02-18 | 刘玲 | Medicine for treating insulin dependent diabetes mellitus as well as preparation method thereof |
CN104689006A (en) * | 2015-02-16 | 2015-06-10 | 广西世彪药业有限公司 | Medicine for treating diabetes and preparation method of medicine |
CN109157615A (en) * | 2018-08-13 | 2019-01-08 | 李阳 | It is a kind of to treat diabetes Chinese prescription |
-
1995
- 1995-01-10 CN CN 95101100 patent/CN1111522A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071120C (en) * | 1996-03-06 | 2001-09-19 | 宫君平 | Shihua drink made from traditional Chinese medicine |
CN1067260C (en) * | 1997-05-08 | 2001-06-20 | 曾力群 | Pure Chinese drug tangniaojing for curing diabetes |
CN1075735C (en) * | 1999-09-07 | 2001-12-05 | 阎纯义 | Compound diabetes-treating Chinese medicine preparation |
CN100415270C (en) * | 2000-10-20 | 2008-09-03 | 孙喆 | Diabetes treating medicine |
CN102614405B (en) * | 2012-04-06 | 2015-03-11 | 刘英晓 | Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy |
CN102614405A (en) * | 2012-04-06 | 2012-08-01 | 刘英晓 | Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy |
CN103463407A (en) * | 2013-03-24 | 2013-12-25 | 季成玉 | Body regulating and blood sugar reducing capsule |
CN103463407B (en) * | 2013-03-24 | 2016-06-08 | 季成玉 | Reason machine Jiangtang capsule |
CN103690768A (en) * | 2013-11-18 | 2014-04-02 | 山西五台山沙棘制品有限公司 | Creeping liriope-figwort-milkvetch root soft capsules and preparation method thereof |
CN103690768B (en) * | 2013-11-18 | 2016-05-11 | 山西五台山沙棘制品有限公司 | Join stilbene soft capsule and preparation method thereof the tuber of dwarf lilyturf |
CN104352863A (en) * | 2014-11-14 | 2015-02-18 | 刘玲 | Medicine for treating insulin dependent diabetes mellitus as well as preparation method thereof |
CN104689006A (en) * | 2015-02-16 | 2015-06-10 | 广西世彪药业有限公司 | Medicine for treating diabetes and preparation method of medicine |
CN109157615A (en) * | 2018-08-13 | 2019-01-08 | 李阳 | It is a kind of to treat diabetes Chinese prescription |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5908628A (en) | Compositions with analgesic, antipyretic and antiinflammatory properties | |
CN101708302B (en) | Chinese medicinal preparation for treating diabetes and preparation method thereof | |
CN100408064C (en) | Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine | |
CN1305844A (en) | Medicine for treating congestive heart failure | |
CN100339120C (en) | External applied medicine for treating prickly heat | |
CN1111522A (en) | Compound islets Langerhans regenerated capsule | |
CN100522226C (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
CN1329067C (en) | Traditional Chinese medicine prepn. for treating diabetes | |
CN104225472B (en) | A kind of Chinese medicine preparation and preparation method and purposes for treating Oral mucosal lesion | |
CN1054748C (en) | Medicine for acne | |
CN1077896A (en) | Medicine for psoriasis and manufacture method | |
CN1060368C (en) | Traditional Chinese medicine Jinjiangkebao for treating cough | |
CN1127344C (en) | Oral pill for curing diabetes and its complication | |
CN102652821B (en) | Traditional Chinese medicine extract for treating yin deficiency and fire hyperactivity type phthisis and preparation method of traditional Chinese medicine extract | |
CN1063066C (en) | Chinese medicine for treatment of gout | |
CN1241634C (en) | Medicine for treating diabetes | |
CN1087821A (en) | A kind of medicament and preparation method of removing acne | |
CN1117575C (en) | Drug-dropping Chinese patent medicine for improving immunity of human body itself | |
CN108704064A (en) | A kind of Chinese medicine composition and preparation method for treating AIDS | |
CN1100319A (en) | Pancreatic islet recovering capsule and its preparing method | |
CN1259363A (en) | Complex prescription capsule for strengthening yang and tonifying kidney and prepn. method thereof | |
CN1164283C (en) | Pulmonotis treating Chinese medicine powder | |
CN1294934C (en) | Prepared Chinese medicine for treating dribble urination caused by accumlated damp-heat and urination distrubance disease with dripping wet and unsmooth | |
CN1232673A (en) | Chinese herbal decoction as oral liquid and its preparation and application | |
CN1306830A (en) | Medicine for treating type II diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |